Here, we attempted to construct an autophagy-related prognostic risk signature based on the expression profile of autophagy-related genes (ARGs) for predicting the long-term outcome and effect of precise treatments for ccRCC patients. The gene discussed is SERPINA2; the disease is nonpapillary renal cell carcinoma.